Visualant, a Seattle-based company that offers authentication and diagnostic solutions, today announced a partnership with Intellectual Ventures to spur commercialization of Visualant’s ChromaID technology.
ChromaID uses light-based, spectral-pattern matching for identification applications in the security, medical, agricultural and industrial markets. The patented technology directs light onto a substance or material and allows for detection and diagnostic markers that the human eye can’t pick up.
The new partnership will provide Visualant access to IV’s network of inventors, who will use ChromaID to build solutions for customers involved in medical diagnostics, and food and drug safety. IV will file a minimum of 10 patents with ChromaID technology.
“Our new partnership with Intellectual Ventures is a tremendous validation of our technology,” Visualant founder and CEO Ron Erickson said in a press release. “Partnering with IV puts our technology in the hands of the world’s strongest IP development company, and its network of inventors and engineers.
Terms of the partnership were not disclosed.